LogoLogoMSF Science Portal
  • My saved items
logo

© Médecins Sans Frontières

MSF Science Portal
About MSF Science Portal
About MSF
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use

v2.1.4829.produseast1

Journal Article > Commentary

Fighting poor-quality medicines in low- and middle-income countries: the importance of advocacy and pedagogy

Ravinetto R, Vandenbergh D, Macé C, Pouget C, Renchon B, Rigal J, Schiavetti B, Caudron JM
Download
Download
Abstract
The globalization of pharmaceutical production has not been accompanied by a strengthening and harmonization of the regulatory systems worldwide. Thus, the global market is characterized today by a situation of multiple standards, and patients in low- and middle-income countries are exposed to the risk of receiving poor-quality medicines. Among those who first raised the alarm on this problem, there were pioneering humanitarian groups, who were in a privileged position to witness the gap in quality of medicines between high-income countries and low- and middle-income countries.

Despite an increasing awareness of the problem and the launch of some positive initiatives, the divide in pharmaceutical quality between the North and the South remains important, and insufficiently addressed. More advocacy is needed for universal access to quality-assured medicines. It should target all those who are strongly "involved" with medicines: regulators, international organizations, journalists, purchasers, prescribers, program managers, policy makers, public health actors and the patients. Advocacy should be based on evidence from research and monitoring programs, and technical concepts should be translated in lay language through communication tools that address all the stakeholders. The fight to ensure universal access to quality medicines needs the participation of all, and can only be successful if grounded in common understanding.
Subject Area
access to health care
DOI
10.1186/s40545-016-0088-0
Published Date
10-Nov-2016
PubMed ID
27843547
Languages
English
Journal
Journal of Pharmaceutical Policy and Practice
Volume / Issue / Pages
Volume 9, Issue 1, Pages 36
Issue Date
10-Nov-2016
Dimensions Badge